Literature DB >> 35024076

Erdheim-Chester disease with multisystem involvement evaluated by multimodal imaging: A case report.

Jing Liu1, Limin Gao2, Huaxia Pu1, Wenzhang He1, Liqing Peng1.   

Abstract

Erdheim-Chester disease is a rare, idiopathic, multisystemic non-Langerhans cell histiocytosis. Little is known about the imaging features. Herein, we report a very uncommon case of Erdheim-Chester disease in a 54-year-old woman with multisystem involvement including cardiovascular system, skeleton, retroperitoneum (renal and adrenal infiltration), orbit and pituitary. Multimodal imaging modalities, including computed tomography, magnetic resonance imaging, echocardiography, and bone scintigraphy were used to comprehensively evaluate different organs involvement. Finally, myocardial biopsy results indicated Erdheim-Chester disease. Electrocardiography showed sick sinus syndrome and slowest heart rate of 20 beats/min. The patient underwent permanent pacemaker implantation and had initial treatment with interferon. There were no remarkable changes in right atrial lesion during 9-month follow-up period. Erdheim-Chester disease was a rare entity with a dismal prognosis, especially when there were cardiac and neurological involvement. The present case report aimed to described and analyzed radiological findings of multiple organs involvement of Erdheim-Chester disease with multimodal imaging retrospectively, and being familiar with the imaging features of Erdheim-Chester disease might help prompt and correct diagnosis of this disease in the future.
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  CT, Computed tomography; Case report; Computed tomography; ECD, Erdheim-Chester disease; Erdheim-Chester disease; MRI, Magnetic resonance imaging; Magnetic resonance imaging; Multimodal imaging; RA, Right atrium; SSFP, Steady state free procession; T1WI, T1 weighted imaging; T2WI, T2 weighted imaging

Year:  2021        PMID: 35024076      PMCID: PMC8727891          DOI: 10.1016/j.radcr.2021.11.076

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Erdheim-Chester disease (ECD) is a rare, idiopathic, systemic non-Langerhans cell histiocytosis, characterized by tissue infiltration by large amount of non-Langerhans foamy histiocytes (CD 68+, CD1a- and S100-) and chronic inflammation [1]. ECD frequently involves multiple organs and systems including the skeleton (74%), neurologic system (25%∼50%), cardiovascular (36%), retroperitoneum (more than 33%), skin (27%), orbit (25%), and pulmonary (18%) [2]. Most of these organs and systems were involved in our case, including cardiovascular (right atrium, interatrial septum, and atrioventricular sulcus, aorta, renal artery, and celiac artery), skeleton, retroperitoneum (renal and adrenal infiltration), orbit, and neurologic system (pituitary). A ECD patient with involvement of so many organs has rarely been reported in literature. In general, the ECD patients had poor prognosis. A systematic review (n = 448) showed that the median age at death, and mean survival time after diagnosis were 56 years old and 2.3 years, respectively [2]. Estrada-Veras et al. [3] indicated that the patients with cardiac and neurological involvement should be paid special attention due to their association with increased morbidity and mortality. Due to its poor prognosis, early correct diagnosis is necessary for this extremely rare entity. Herein, we presented multimodal images in comprehensively assessing imaging features in each system, and meanwhile we also showed detailed clinical manifestations in this report.

Case presentation

A 54-year-old woman was referred to the emergency department in our institution for complaining of exertional dyspnea, palpitation, fatigue, dizziness, and mild pitting edema of lower extremities over the last 4 years. The initial blood pressure was 125/77 mm Hg. She had a medical history of diabetes insipidus, chronic osteomyelitis, well-controlled hypertension and hyperthyroidism. Laboratory examination showed the erythrocyte sedimentation rate (100 mm/h), C-reaction protein (42.4 mg/l), and type B natriuretic peptide (2137 ng/l), interleukin-6 (61.3 pg/ml), white blood cell count (15.7 × 109/l), and platelet count (653 × 109/l) were significantly elevated. The level of the tumor marker serum carbohydrate antigen-199 (32.93 U/ml) was slightly increased. Her daily urine output was greater than 10,000 ml. The cardiac computed tomography (CT) showed a soft tissue lesion with inhomogeneous density and unclear boundary that infiltrated right atrium (RA) wall, interatrial septum, and atrioventricular sulcus with small pericardial effusion. The lesion was slightly enhanced after administration of contrast agent. Coronary CT angiography showed that the right coronary artery was encased by the lesion without luminal stenosis. Perivascular infiltration of the aorta, called “coated aorta”, also can be observed (Fig. 1). For further evaluating cardiac function and characterizing the lesion, cardiac magnetic resonance imaging (MRI) and transthoracic echocardiography were performed. The cardiac MRI showed that cardiac lesion was mildly inhomogeneous hypertense on T2-weighted bright-blood images and hypointense on cine steady state free procession (SSFP) image. After gadolinium administration, the cardiac lesion was gradually and heterogeneously enhanced from first-pass myocardial perfusion to late gadolinium enhancement (Fig. 2). Echocardiography demonstrated a hypoechoic mass on the RV wall with enhancement after contrast agent injection (Fig. 3). The patient had normal global left ventricular systolic function with an ejection fraction of 63%.
Fig. 1

CT demonstrating cardiovascular involvement of Erdheim-Chester disease. (A) Unenhanced CT shows a soft tissue density lesion with inhomogeneous density and unclear boundary that infiltrates RA wall, interatrial septum, and atrioventricular sulcus (arrows) with small pericardial effusion. (B) the lesion is slightly enhanced after administration of contrast agent. (C) shows perivascular infiltration of the aorta, called “coated aorta”. (D) Coronary CT angiography shows that the right coronary artery is encased by the lesion without luminal stenosis. CT, Computed tomography; RA, right atrium; AO, Aorta; RCA, right coronary artery.

Fig. 2

Cardiac magnetic resonance showing cardiac involvement. An irregularly contoured lesion with infiltrating the right atrium wall, atrioventricular groove and interatrial septum is shown mildly inhomogeneous hypertense on transverse (A, arrows) and coronal (B) T2-weighted bright-blood images, hypointense on cine SSFP image (C); (D), (E), and (F) after administration of contrast agent, the cardiac lesion is gradually and heterogeneously enhanced from first-pass myocardial perfusion to late gadolinium enhancement. SSFP, steady-state free precession.

Fig. 3

Echocardiography showing cardiac involvement. (A) Echocardiography shows a mass on right atrium wall (arrow); (B) and the mass is enhanced after contrast agent injection.

CT demonstrating cardiovascular involvement of Erdheim-Chester disease. (A) Unenhanced CT shows a soft tissue density lesion with inhomogeneous density and unclear boundary that infiltrates RA wall, interatrial septum, and atrioventricular sulcus (arrows) with small pericardial effusion. (B) the lesion is slightly enhanced after administration of contrast agent. (C) shows perivascular infiltration of the aorta, called “coated aorta”. (D) Coronary CT angiography shows that the right coronary artery is encased by the lesion without luminal stenosis. CT, Computed tomography; RA, right atrium; AO, Aorta; RCA, right coronary artery. Cardiac magnetic resonance showing cardiac involvement. An irregularly contoured lesion with infiltrating the right atrium wall, atrioventricular groove and interatrial septum is shown mildly inhomogeneous hypertense on transverse (A, arrows) and coronal (B) T2-weighted bright-blood images, hypointense on cine SSFP image (C); (D), (E), and (F) after administration of contrast agent, the cardiac lesion is gradually and heterogeneously enhanced from first-pass myocardial perfusion to late gadolinium enhancement. SSFP, steady-state free precession. Echocardiography showing cardiac involvement. (A) Echocardiography shows a mass on right atrium wall (arrow); (B) and the mass is enhanced after contrast agent injection. The abdominal CT scan showed soft tissue density lesion with irregular contour and mild enhancement that involved retroperitoneal organs (bilateral adrenal glands and kidneys) and fat gap. Due to the infiltration of perirenal fat and fascia, it had a “hairy kidney” appearance. Meanwhile, mild hydronephrosis was observed in the left kidney. In addition, we found vascular involvement of the retroperitoneum, presented with severe stenosis of the proximal segment of celiac artery and left renal artery (Fig. 4). Sella turcica MRI was used to determine whether diabetes insipidus was caused by pituitary affection, and the MRI revealed thickening and homogeneous enhancement of pituitary stalk with patch enhancement in clivus (Fig. 5). Furthermore, laboratory examinations for tuberculosis, pituitary function (adrenocorticotropic hormone, luteinizing hormone, and follicle-stimulating hormone), adrenal function (morning serum cortisol), thyroid function, and immune diseases were all negative. The biopsy of retroperitoneal or cardiac lesion has not yet been performed due to the poor physical condition of the patient. Eventually, the patient was managed conservatively with diuretics and antihypertensive drugs. After three weeks of conservative treatment, the symptoms of the patient were relieved and asked to be discharged from the hospital.
Fig. 4

Computed tomography demonstrating retroperitoneal infiltration of Erdheim-Chester disease. (A) and (B) show infiltration in bilateral kidneys (“hairy kidney”), adrenal glands, and retroperitoneal fat gap; meanwhile, there is mild hydronephrosis in the left kidney. (C) and (D) reveal the severe stenosis of the proximal of celiac artery and left renal artery. CA, celiac artery; LRA, left renal artery.

Fig. 5

Sella turcica magnetic resonance imaging demonstrating pituitary gland and clivus involvement. Thickening and enhanced of pituitary stalk and patch enhancement area in clivus (arrows) in sagittal (A) and coronal position (B).

Computed tomography demonstrating retroperitoneal infiltration of Erdheim-Chester disease. (A) and (B) show infiltration in bilateral kidneys (“hairy kidney”), adrenal glands, and retroperitoneal fat gap; meanwhile, there is mild hydronephrosis in the left kidney. (C) and (D) reveal the severe stenosis of the proximal of celiac artery and left renal artery. CA, celiac artery; LRA, left renal artery. Sella turcica magnetic resonance imaging demonstrating pituitary gland and clivus involvement. Thickening and enhanced of pituitary stalk and patch enhancement area in clivus (arrows) in sagittal (A) and coronal position (B). Recently, the patient was referred to cardiology clinic, owning to the aforementioned symptoms aggravation and new symptoms occurrence (abdominal distention and syncope). The follow-up cardiac CT demonstrated disease progression due to the increased extent of lesion infiltration in the right adrenal gland, right kidney, and retroperitoneal fat gap when compared with images in first admission. Brain MRI showed a right retrobular mass with isointense signal on T1 weighted imaging (T1WI) and slightly hypointense signal on T2 weighted imaging (T2WI) (Fig. 6). Bone scintigraphy showed increased radiotracer uptake in skull and bilateral symmetric long bones of extremities, especially in the distal femur and proximal tibia. Electrocardiography showed sick sinus syndrome and slowest heart rate of 20 beats/min. Finally, the patient underwent permanent artificial pacemaker implantation. In order to confirm the diagnosis, the patient underwent myocardial biopsy of the right atrium. Histopathology revealed infiltration characterized by large amount of non-Langerhans foamy histiocytes (CD 68+, CD1a-, S100-, and Langerin-) and inflammation cells (Fig. 7), which is a distinctive histopathological feature of ECD. The genomic evaluation revealed that BRAFV600E mutation was negative. The patient had initial treatment with interferon after discharge with regular follow-up. There were no remarkable changes in right atrial lesion during 9-month follow-up period.
Fig. 6

Brain magnetic resonance imaging demonstrating a right intraconal lesion. A right intraconal lesion (arrows) with isointense signal on T1-weighted image (A) and slightly hypointense signal on T2-weighted image (B).

Fig. 7

Histopathology findings. (A) Hematoxylin and eosin stain for myocardial biopsy specimen shows foamy macrophages (arrow, original magnification × 200); (B) immunohistochemistry shows that histiocytes are strongly positive for CD68 protein (original magnification × 200).

Brain magnetic resonance imaging demonstrating a right intraconal lesion. A right intraconal lesion (arrows) with isointense signal on T1-weighted image (A) and slightly hypointense signal on T2-weighted image (B). Histopathology findings. (A) Hematoxylin and eosin stain for myocardial biopsy specimen shows foamy macrophages (arrow, original magnification × 200); (B) immunohistochemistry shows that histiocytes are strongly positive for CD68 protein (original magnification × 200).

Discussion

ECD was a rare multisystem disorder of xanthomatous infiltration by non-Langerhans cell histiocytosis, with a slightly male predominance (62.3%) and the median age at diagnosis was 52.8 years [2]. Underlying etiology of ECD remains uncertain. Recent findings suggested that ECD was a rare clonal disorder, driven by mutations of the mitogen-activated protein kinase/extracellular signal–regulated kinase pathway, with a high frequency of BRAFV600E mutation (in >50% of cases), in which chronic inflammation environment was considered as an important mediator of ECD pathogenesis [1]. The diagnosis of ECD is based on supported histopathological findings with appropriate clinical manifestations and radiographic context. The clinical manifestations mainly depended on the affected organs. In our case, the patient mainly presented with cardiac tamponade or right heart failure (exertional dyspnea, fatigue and lower extremity pitting edema), sick sinus syndrome (syncope, palpitation and dizziness), diabetes insipidus symptoms (polyuria) due to heart (myocardium and pericardium) and pituitary involvement. Retroperitoneal involvement was often asymptomatic in previous literature [2]. However, abdominal distention in our case may be explained by retroperitoneal infiltration. In addition, the secondary systemic hypertension can be caused by renovascular involvement [4,5]. Not only renovascular involvement but also periaortic or other vascular infiltration was found in our case, which may be risk factors for hypertension. Radiology is essential for diagnosing and managing ECD. Therefore, to make a correct diagnosis, consensus guidelines indicated that all patients with suspicion of ECD needed to conduct CT (chest, abdomen, and pelvis), positron emission tomography/computed tomography scan, brain and cardiac MRI. In addition, other radiological examinations could be selected according to clinical symptoms or signs [1]. Cardiovascular involvement is common in ECD patients and it is associated with a worse prognosis [6]. A contrast-enhanced cardiac MRI is optimal to evaluate the extent of myocardial and pericardial infiltration, tissue characterization of the lesion, and ventricular dysfunction. Differential diagnosis for ECD with involvement of the heart mainly includes primary cardiac lymphoma and angiosarcoma. Differentiating ECD from primary cardiac lymphoma is challenging. The primary cardiac lymphoma can be hypointense on T1WI and hyperintense on T2WI, but it often demonstrates heterogeneous signal with mildly homogenous or heterogeneous contrast enhancement [7]. In our report, cardiac lesion was gradually and heterogeneously intensified from first-pass myocardial perfusion to late gadolinium enhancement and presented finally significant enhancement on late gadolinium enhancement. The pattern of enhancement may be useful in diagnosis and differential diagnosis of ECD. Additionally, angiosarcomas with irregular cauliflower formation often involve free wall of the right atrium and are mostly heterogeneous due to the content of hemorrhage, vessels, or necrosis. After contrast media administration, angiosarcomas typically show marked heterogeneous or rim enhancement [8]. Treatment of ECD has yet to be fully established. Consensus guidelines indicated that initiation of therapy was recommended for all patients, except for those patients who were asymptomatic, and interferon was the most commonly prescribed therapy according to literature [1]. A prospective and multicenter study with 53 ECD patients confirmed that interferon significantly improved overall survival [9]. For BRAF-positive patients, vemurafenib, as an inhibitor of mutated BRAF, was effective with evidence of dramatic clinical and radiographic improvement [10]. Our report also support the view that the patients with ECD need specific treatment for etiology rather than observation or only symptomatic treatment because of disease deterioration over time in our patient. Due to lacking BRAFV600E mutation, our patient had initial treatment with interferon and regular follow-up.

Conclusion

In conclusion, this report shows a rare case of ECD with multisystem involvement, comprehensively assessed by multimodal imaging. Be familiar with the imaging and clinical features of ECD is essential for prompt and correct diagnosis and management of this disease.

Ethical approval

The present report was approved by the Ethics Committee of the West China Hospital in Sichuan University.

Patient consent

Written informed consent was obtained from the patient for the publication of this case report.

Declaration of Competing Interest

The authors have declared that no competing interests exist.
  10 in total

1.  Cardiovascular Manifestations of Erdheim-Chester's Disease: A Case Series.

Authors:  Isabela Bispo Santos da Silva Costa; André Neder Ramires Abdo; Cristina Salvadori Bittar; Silvia Moulin Ribeiro Fonseca; Aline Sabrina Holanda Teixeira Moraes; Roberto Kalil Filho; Juliana Pereira; Ludhmila Abrahão Hajjar
Journal:  Arq Bras Cardiol       Date:  2018-12       Impact factor: 2.000

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 3.  Erdheim-Chester disease: a systematic review.

Authors:  Mauro Cives; Valeria Simone; Francesca Maria Rizzo; Franca Dicuonzo; Marirosa Cristallo Lacalamita; Giuseppe Ingravallo; Franco Silvestris; Franco Dammacco
Journal:  Crit Rev Oncol Hematol       Date:  2015-02-17       Impact factor: 6.312

4.  CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.

Authors:  Laurent Arnaud; Baptiste Hervier; Antoine Néel; Mohamed A Hamidou; Jean-Emmanuel Kahn; Bertrand Wechsler; Gemma Pérez-Pastor; Bjørn Blomberg; Jean-Gabriel Fuzibet; François Dubourguet; António Marinho; Catherine Magnette; Violaine Noel; Michel Pavic; Jochen Casper; Anne-Bérangère Beucher; Nathalie Costedoat-Chalumeau; Laurent Aaron; Juan Salvatierra; Carlos Graux; Patrice Cacoub; Véronique Delcey; Claudia Dechant; Pascal Bindi; Christiane Herbaut; Giorgio Graziani; Zahir Amoura; Julien Haroche
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

5.  The clinical spectrum of Erdheim-Chester disease: an observational cohort study.

Authors:  Juvianee I Estrada-Veras; Kevin J O'Brien; Louisa C Boyd; Rahul H Dave; Benjamin Durham; Liqiang Xi; Ashkan A Malayeri; Marcus Y Chen; Pamela J Gardner; Jhonell R Alvarado-Enriquez; Nikeith Shah; Omar Abdel-Wahab; Bernadette R Gochuico; Mark Raffeld; Elaine S Jaffe; William A Gahl
Journal:  Blood Adv       Date:  2017-02-14

6.  Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.

Authors:  Julien Haroche; Fleur Cohen-Aubart; Jean-François Emile; Laurent Arnaud; Philippe Maksud; Frédéric Charlotte; Philippe Cluzel; Aurélie Drier; Baptiste Hervier; Neïla Benameur; Sophie Besnard; Jean Donadieu; Zahir Amoura
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

7.  Bilateral renal artery involvement of erdheim-chester disease.

Authors:  Andrew A Yaeger; Fred A Weaver; Karen Woo
Journal:  Ann Vasc Surg       Date:  2014-04-02       Impact factor: 1.466

8.  Erdheim-Chester Disease Presenting with Secondary Hypertension as a Result of Bilateral, Proximal Renal Artery Stenosis: A Case Report.

Authors:  Farid Arman; Hania Shakeri; Niloofar Nobakht; Anjay Rastogi; Mohammad Kamgar
Journal:  Case Rep Nephrol Dial       Date:  2017-05-23

9.  Multimodality imaging evaluation of a primary cardiac lymphoma.

Authors:  Paolo Ciancarella; Armando Fusco; Daniele Citraro; Massimiliano Sperandio; Roberto Floris
Journal:  J Saudi Heart Assoc       Date:  2016-09-20

10.  "Sun Ray" Appearance in a Case of Cardiac Angiosarcoma: A Comparison of MRI and PET/CT.

Authors:  Zbyněk Tüdös; Martin Köcher; Marie Černá; František Odstrčil; Zuzana Prouzová; Radim Formánek; Jan Přeček
Journal:  Magn Reson Med Sci       Date:  2016-03-21       Impact factor: 2.471

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.